Literature DB >> 29124400

Characterization of M1 and M2 polarization of macrophages in vascularized human dermo-epidermal skin substitutes in vivo.

Agnes S Klar1,2, Katarzyna Michalak-Mićka3,4, Thomas Biedermann3,4, Claudia Simmen-Meuli5, Ernst Reichmann3,4, Martin Meuli6,4.   

Abstract

AIMS AND
OBJECTIVES: Vascularized bio-engineered human dermo-epidermal skin substitutes (vascDESS) hold promise for treating burn patients, including those with severe full-thickness wounds. We have previously shown that vascDESS promote wound healing by enhanced influx of macrophages and granulocytes. Immediately following transplantation, macrophages infiltrate the graft and differentiate into a pro-inflammatory (M1) or a pro-healing M2 phenotype. The aim of this study was to characterize the activation state of macrophages infiltrating skin transplants at distinct time points following transplantation.
METHODS: Keratinocytes and the stromal vascular fraction (SVF) were derived from human skin or adipose tissue, respectively. Human SVF containing both endothelial and mesenchymal/stromal cells was used to generate vascularized dermal component in vitro, which was subsequently covered with human keratinocytes. Finally, vascDESS were transplanted on the back of immuno-incompetent rats, excised, and analyzed after 1 and 3 weeks using immunohistological techniques.
RESULTS: A panel of markers of macrophage M1 (nitric oxide synthase: iNOS) and M2 (CD206) subclass was used. All skin grafts were infiltrated by both M1 and M2 rat macrophages between 1-3 weeks post-transplantation. CD68 (PG-M1) was used as a pan-macrophage marker. The number of CD68+CD206+ M2-polarized macrophages was higher in 3-week transplants as compared to early-stage transplants (1 week). In contrast, the number of CD68+iNOS+ M1 cells was markedly decreased in later stages in vivo.
CONCLUSIONS: Macrophages exhibit a heterogeneous and temporally regulated polarization during skin wound healing. Our results suggest that the phenotype of macrophages changes during healing from a more pro-inflammatory (M1) profile in early stages after injury, to a less inflammatory, pro-healing (M2) phenotype in later phases in vivo.

Entities:  

Keywords:  Adipose stem cells; Macrophages; Skin tissue engineering

Mesh:

Substances:

Year:  2017        PMID: 29124400     DOI: 10.1007/s00383-017-4179-z

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  33 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

2.  Systematic validation of specific phenotypic markers for in vitro polarized human macrophages.

Authors:  C A Ambarus; S Krausz; M van Eijk; J Hamann; T R D J Radstake; K A Reedquist; P P Tak; D L P Baeten
Journal:  J Immunol Methods       Date:  2011-10-29       Impact factor: 2.303

Review 3.  Inflammatory cells during wound repair: the good, the bad and the ugly.

Authors:  Paul Martin; S Joseph Leibovich
Journal:  Trends Cell Biol       Date:  2005-10-03       Impact factor: 20.808

Review 4.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

5.  Distinct macrophage phenotypes contribute to kidney injury and repair.

Authors:  Sik Lee; Sarah Huen; Hitoshi Nishio; Saori Nishio; Heung Kyu Lee; Bum-Soon Choi; Christiana Ruhrberg; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

Review 6.  Role of macrophages in normal wound healing: an overview.

Authors:  R Adamson
Journal:  J Wound Care       Date:  2009-08       Impact factor: 2.072

Review 7.  Innate and adaptive immune responses to cell death.

Authors:  Kenneth L Rock; Jiann-Jyh Lai; Hajime Kono
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

8.  Tissue-engineered dermo-epidermal skin grafts prevascularized with adipose-derived cells.

Authors:  Agnieszka S Klar; Sinan Güven; Thomas Biedermann; Joachim Luginbühl; Sophie Böttcher-Haberzeth; Claudia Meuli-Simmen; Martin Meuli; Ivan Martin; Arnaud Scherberich; Ernst Reichmann
Journal:  Biomaterials       Date:  2014-03-27       Impact factor: 12.479

9.  Urokinase-type plasminogen activator contributes to heterogeneity of macrophages at the border of damaged site during liver repair in mice.

Authors:  N Kawao; N Nagai; Y Tamura; K Okada; M Yano; Y Suzuki; K Umemura; S Ueshima; O Matsuo
Journal:  Thromb Haemost       Date:  2011-02-08       Impact factor: 5.249

10.  Analysis of blood and lymph vascularization patterns in tissue-engineered human dermo-epidermal skin analogs of different pigmentation.

Authors:  Agnieszka S Klar; Sophie Böttcher-Haberzeth; Thomas Biedermann; Clemens Schiestl; Ernst Reichmann; Martin Meuli
Journal:  Pediatr Surg Int       Date:  2014-02       Impact factor: 1.827

View more
  21 in total

1.  Imaging and Characterization of Macrophage Distribution in Mouse Models of Human Prostate Cancer.

Authors:  Ben T Copeland; Hassan Shallal; Chentian Shen; Kenneth J Pienta; Catherine A Foss; Martin G Pomper
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

Review 2.  The role of macrophages in thermal injury.

Authors:  Julia A Penatzer; Shruthi Srinivas; Rajan K Thakkar
Journal:  Int J Burns Trauma       Date:  2022-02-15

3.  IL-10 Dysregulation Underlies Chemokine Insufficiency, Delayed Macrophage Response, and Impaired Healing in Diabetic Wounds.

Authors:  Ruchi Roy; Janet Zayas; Mohamed F Mohamed; Anahita Aboonabi; Kaylee Delgado; Jennillee Wallace; Mohammad Bayat; Timothy M Kuzel; Jochen Reiser; Sasha H Shafikhani
Journal:  J Invest Dermatol       Date:  2021-09-10       Impact factor: 7.590

4.  A Novel Three-Dimensional Skin Disease Model to Assess Macrophage Function in Diabetes.

Authors:  Avi Smith; Trishawna Watkins; Georgios Theocharidis; Irene Lang; Maya Leschinsky; Anna Maione; Olga Kashpur; Theresa Raimondo; Sahar Rahmani; Jeremy Baskin; David Mooney; Aristidis Veves; Jonathan Garlick
Journal:  Tissue Eng Part C Methods       Date:  2021-01-20       Impact factor: 3.056

Review 5.  Immune Cell Therapies to Improve Regeneration and Revascularization of Non-Healing Wounds.

Authors:  Elena Groppa; Andrea Colliva; Roman Vuerich; Tea Kocijan; Serena Zacchigna
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

6.  Functional aspects, phenotypic heterogeneity, and tissue immune response of macrophages in infectious diseases.

Authors:  Jorge Rodrigues de Sousa; Pedro Fernando Da Costa Vasconcelos; Juarez Antonio Simões Quaresma
Journal:  Infect Drug Resist       Date:  2019-08-22       Impact factor: 4.003

Review 7.  Tissue engineering in pediatric urology - a critical appraisal.

Authors:  Frank-Mattias Schäfer; Maximilian Stehr
Journal:  Innov Surg Sci       Date:  2018-05-25

8.  Acetylation-Dependent Regulation of Notch Signaling in Macrophages by SIRT1 Affects Sepsis Development.

Authors:  Xiaozhi Bai; Ting He; Yang Liu; Julei Zhang; Xiaoqiang Li; Jihong Shi; Kejia Wang; Fu Han; Wei Zhang; Yijie Zhang; Weixia Cai; Dahai Hu
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

9.  High-fluence low-power laser irradiation promotes odontogenesis and inflammation resolution in periodontitis by enhancing stem cell proliferation and differentiation.

Authors:  Tiejun Hou; Shanyong Li; Guangwei Zhang; Yan Li
Journal:  Int J Mol Med       Date:  2018-08-02       Impact factor: 4.101

10.  Increased CD68/TGFβ Co-expressing Microglia/ Macrophages after Transient Middle Cerebral Artery Occlusion in Rhesus Monkeys.

Authors:  Hyeon-Gu Yeo; Jung Joo Hong; Youngjeon Lee; Kyung Sik Yi; Chang-Yeop Jeon; Junghyung Park; Jinyoung Won; Jincheol Seo; Yu-Jin Ahn; Keonwoo Kim; Seung Ho Baek; Eun-Ha Hwang; Green Kim; Yeung Bae Jin; Kang-Jin Jeong; Bon-Sang Koo; Philyong Kang; Kyung Seob Lim; Sun-Uk Kim; Jae-Won Huh; Young-Hyun Kim; Yeonghoon Son; Ji-Su Kim; Chi-Hoon Choi; Sang-Hoon Cha; Sang-Rae Lee
Journal:  Exp Neurobiol       Date:  2019-08-31       Impact factor: 3.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.